Cellosaurus logo
expasy logo

Cellosaurus GSC#76 (CVCL_A9TK)

[Text version]
Cell line name GSC#76
Accession CVCL_A9TK
Resource Identification Initiative To cite this cell line use: GSC#76 (RRID:CVCL_A9TK)
Comments Group: Cancer stem cell line.
From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
Disease Glioblastoma (NCIt: C3058)
Glioblastoma (ORDO: Orphanet_360)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Age at sampling 48Y
Category Cancer cell line
STR profile Source(s): PubMed=33128777

Markers:
AmelogeninX
CSF1PO12
D5S81810
D7S8208,12
D13S31712
D16S53912
TH017
TPOX11
vWA17

Run an STR similarity search on this cell line
Publications

PubMed=21102434; DOI=10.1038/nature09557
Ricci-Vitiani L., Pallini R., Biffoni M., Todaro M., Invernici G., Cenci T., Maira G., Parati E.A., Stassi G., Larocca L.M., De Maria R.
Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells.
Nature 468:824-828(2010)

PubMed=28204560; DOI=10.1093/neuonc/now304
D'Alessandris Q.G., Biffoni M., Martini M., Runci D., Buccarelli M., Cenci T., Signore M., Stancato L., Olivi A., De Maria R., Larocca L.M., Ricci-Vitiani L., Pallini R.
The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response.
Neuro-oncol. 19:1097-1108(2017)

PubMed=28248456; DOI=10.1002/1878-0261.12047
Marziali G., Buccarelli M., Giuliani A., Ilari R., Grande S., Palma A., D'Alessandris Q.G., Martini M., Biffoni M., Pallini R., Ricci-Vitiani L.
A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes.
Mol. Oncol. 11:1115-1129(2017)

PubMed=29531533; DOI=10.1155/2018/3292704
Grande S., Palma A., Ricci-Vitiani L., Luciani A.M., Buccarelli M., Biffoni M., Molinari A., Calcabrini A., D'Amore E., Guidoni L., Pallini R., Viti V., Rosi A.
Metabolic heterogeneity evidenced by MRS among patient-derived glioblastoma multiforme stem-like cells accounts for cell clustering and different responses to drugs.
Stem Cells Int. 2018:3292704.1-3292704.16(2018)

PubMed=33128777; DOI=10.1002/ijc.33370
Visconti P., Parodi F., Parodi B., Casarino L., Romano P., Buccarelli M., Pallini R., D'Alessandris Q.G., Montori A., Pilozzi E., Ricci-Vitiani L.
Short tandem repeat profiling for the authentication of cancer stem-like cells.
Int. J. Cancer 148:1489-1498(2021)

Cross-references
Encyclopedic resources Wikidata; Q102114068
Entry history
Entry creation29-Oct-2020
Last entry update29-Jun-2023
Version number4